Download PDFPDF

1440 Arginase-1 peptide-based vaccine is an exciting approach to modulate the tumor microenvironment and drive efficacy in preclinical tumor models
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address